98%
921
2 minutes
20
Background: Artificial intelligence (AI) has the potential to improve health care delivery through enhanced diagnostics, streamlined operations, and predictive analytics. However, health care organizations face substantial challenges in implementing AI safely and responsibly. This is due to regulatory complexity, ethical considerations, and a lack of practical governance frameworks. While many theoretical frameworks exist, few have been tested or adapted for real-world application in health care settings.
Objective: This study aims to develop and validate a practical AI governance framework to support the safe and responsible use of AI in health care organizations. The specific objectives are to identify governance requirements for AI in health care, examine existing AI governance processes and best practices, codevelop an AI governance framework to meet the needs of health care organizations, and test and refine the framework through real-world application.
Methods: A multimethod research design will be used, comprising four key stages: (1) a scoping review and document analysis to identify governance needs and current processes, (2) in-depth interviews with health care stakeholders as well as national and international AI governance experts, (3) development of a draft AI governance framework through a synthesis of findings, and (4) validation and refinement of the framework through stakeholder workshops and application to case studies of AI tools. Data will be analyzed using qualitative methods informed by grounded theory.
Results: The project received funding in October 2023. Ethics approval was obtained from the Alfred Health Human Research Ethics Committee (project 171/24) and the Macquarie University Human Research Ethics Committee (project 16508). Data collection commenced in April 2024, with the scoping review and document analysis being finalized. As of March 2025, a total of 43 interviews have been completed. The final AI governance framework is expected to be completed and ready for dissemination by June 2025.
Conclusions: This study will deliver a comprehensive AI governance framework co-designed with health care stakeholders to address real-world challenges in AI oversight. The framework will offer practical guidance to support health care organizations in adopting AI technologies safely, ethically, and in alignment with regulatory requirements. Outcomes from this study will inform local and international discussions on AI governance and promote the responsible integration of AI in health systems.
International Registered Report Identifier (irrid): DERR1-10.2196/75702.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12340452 | PMC |
http://dx.doi.org/10.2196/75702 | DOI Listing |
Wounds
August 2025
Solventum, Maplewood, MN, USA.
Background: Initially limited to inpatient use, negative pressure wound therapy (NPWT) is now frequently used in community settings. However, complexities in wound management step-down strategies in the United Kingdom, including regional variations in referral processes, lack of consensus on funding criteria, and limited availability of NPWT units, have led to extended hospital length of stay (LOS) for patients ready for discharge but still needing NPWT. Single-use NPWT (sNPWT) can serve as a bridge between hospital and community NPWT.
View Article and Find Full Text PDFBackground: This retrospective analysis is a derivative cohort study based on a prior retrospective investigation by this author group.
Objective: To assess the effect of the number of cellular and/or tissue-based product (CTP) applications on healing outcomes and wound area reduction (WAR) rates in patients with chronic wounds of multiple etiologies.
Methods: Data from a multicenter private wound care practice electronic health record database were analyzed for Medicare patients receiving CTPs from January 2018 through December 2023.
Wounds
August 2025
Department of Nursing, Federal University of Ceará, Ceará, Brazil.
Background: Diabetic foot ulcers (DFUs) are a major clinical challenge, particularly among patients with refractory ulcers, that often lead to severe complications such as infection, amputation, and high mortality. Innovations supported by strong clinical evidence have the potential to improve healing outcomes, enhance quality of life, and reduce the economic burden on individuals and health care systems.
Objective: To describe the design of the concurrent optical and magnetic stimulation (COMS) therapy Investigational Device Exemption (IDE) study for refractory DFUs (MAVERICKS) trial.
J Orthop Res
September 2025
Department of Kinesiology, College of Health Sciences, University of Rhode Island, Kingston, Rhode Island, USA.
Arthroplasty surgery is a common and successful end-stage intervention for advanced osteoarthritis. Yet, postoperative outcomes vary significantly among patients, leading to a plethora of measures and associated measurement approaches to monitor patient outcomes. Traditional approaches rely heavily on patient-reported outcome measures (PROMs), which are widely used, but often lack sensitivity to detect function changes (e.
View Article and Find Full Text PDF